Michiel S. Van der Heijden

Neeraj Agarwal: Striking Results in JCO from Ph2b SunRISe-1 Trial

Gil Awada: How Neoadjuvant Immunotherapy is Reshaping the Treatment Landscape Across Solid Tumours

Stephen V Liu: Beautiful Review on Neoadjuvant Immunotherapy Across Tumor Types

Guru Sonpavde: CheckMate 901 Trial Data on First-Line Nivolumab in LN-Only Metastatic Urothelial Carcinoma

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

Andrea Necchi: All you need to know about TAR-200

Nirmal Raut: BEST OF 2024 – Top oncology practice changing trials

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Bladder Cancer

11 ESMO24 presentations published on NEJM

Tom Powles: The 1st perioperative immune therapy study to show an OS in bladder cancer